Doctors are diagnosing more people with melanoma.
2024
Immunotherapy combination improves response in unresectable melanoma
An immunotherapy combination improved outcomes compared with historical control for certain patients with advanced melanoma, according to a topline data announcement.
Site-Specific Melanoma Trends May Be Related to Genetic Risk
WEDNESDAY, July 31, 2024 (HealthDay News) — Site-specific melanoma incidence trends may be partially related to genetic risk, according to a study published online July 19 in the British Journal of Dermatology.
Integrated 15-GEP and PRAME Classifier Shows Prognostic Accuracy in Uveal Melanoma
Integrating 15-GEP with PRAME expression status into a 4-group prognostic classification system showed prognostic accuracy in uveal melanoma.